Search Results - "Morla, Shravan"

Refine Results
  1. 1

    Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation by Morla, Shravan

    “…Glycosaminoglycans (GAGs) are a class of biomolecules expressed virtually on all mammalian cells and usually covalently attached to proteins, forming…”
    Get full text
    Journal Article
  2. 2

    A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation by Boothello, Rio S, Patel, Nirmita J, Sharon, Chetna, Abdelfadiel, Elsamani I, Morla, Shravan, Brophy, Donald F, Lippman, H Robert, Desai, Umesh R, Patel, Bhaumik B

    Published in Molecular cancer therapeutics (01-01-2019)
    “…Targeting of cancer stem cells (CSC) is expected to be a paradigm-shifting approach for the treatment of cancers. Cell surface proteoglycans bearing sulfated…”
    Get full text
    Journal Article
  3. 3

    Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8 by Morla, Shravan, Desai, Umesh R

    Published in Biomolecules (Basel, Switzerland) (09-08-2020)
    “…Elevated matrix metalloproteinase-8 (MMP-8) activity contributes to the etiology of many diseases, including atherosclerosis, pulmonary fibrosis, and sepsis…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin by Deguchi, Hiroshi, Morla, Shravan, Griffin, John H.

    Published in Journal of thrombosis and haemostasis (01-01-2021)
    “…Essentials Striated muscle myosins can promote prothrombin activation by FXa or FVa inactivation by APC. Cardiac myosin and skeletal muscle myosin are…”
    Get full text
    Journal Article
  6. 6

    Procoagulant Activity of Skeletal Muscle Myosin Is Not Caused By Contaminating Phosphatidylserine-Vesicles by Morla, Shravan, Deguchi, Hiroshi, Brekken, Rolf, Griffin, John H.

    Published in Blood (05-11-2020)
    “…Skeletal muscle myosin (SkM) can bind factor (F)Xa and FVa, thereby providing a surface that promotes thrombin generation by the prothrombinase complex…”
    Get full text
    Journal Article
  7. 7

    Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin‐dependent anticoagulant activity by Morla, Shravan, Deguchi, Hiroshi, Griffin, John H.

    Published in Journal of thrombosis and haemostasis (01-02-2021)
    “…Background Heparin enhances the ability of the plasma protease inhibitor, antithrombin, to neutralize coagulation factor Xa and thrombin. Skeletal muscle…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Skeletal Muscle Myosin Is Procoagulant By Binding Factor XI Via Its A3 Domain and Enhancing Factor XI Activation By Thrombin by Deguchi, Hiroshi, Morla, Shravan, Zilberman-Rudenko, Jevgenia, Gruber, Andras, McCarty, Owen J T, Srivastava, Priyanka, Gailani, David, Griffin, John H.

    Published in Blood (23-11-2021)
    “…Blood coagulation mechanisms play key roles in health and disease. Pilot studies using selected human plasmas showed the potential associations of plasma…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation by Morla, Shravan, Deguchi, Hiroshi, Zilberman-Rudenko, Jevgenia, Gruber, András, McCarty, Owen J.T., Srivastava, Priyanka, Gailani, David, Griffin, John H.

    Published in The Journal of biological chemistry (01-02-2022)
    “…Skeletal muscle myosin (SkM) has been shown to possess procoagulant activity; however, the mechanisms of this coagulation-enhancing activity involving plasma…”
    Get full text
    Journal Article
  12. 12

    Selective Inhibition of a Panel of Cancer Stem Cell Lines by Novel Glycosaminoglycan Mimetics by O'Hara, Connor Patrick, Morla, Shravan, Afosah, Daniel, Sharon, Chetna, Boothello, Rio, Patel, Bhaumik, Desai, Umesh

    Published in The FASEB journal (01-04-2019)
    “…Purpose To characterize the anti‐cancer stem cell (CSC) properties of non‐saccharide glycosaminoglycan mimetics (NSGMs) and their lipid‐modified analogs in a…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Abstract 6353: Cholesterol modification enhances potency and pharmacokinetic properties of a selective cancer stem cell targeting agent by O'Hara, Connor P., Boothello, Rio S., Morla, Shravan, Vera, Alberto, Afosah, Daniel K., Sankaranarayanan, Nehru V., Nagarajan, Balaji, Sharon, Chetna, Patel, Bhaumik B., Desai, Umesh R.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Increasing evidence supports the concept that tumor-initiating cancer stem cells (CSCs) are responsible for the relapse and reconstitution of formerly…”
    Get full text
    Journal Article
  16. 16

    On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients by Morla, Shravan, Sankaranarayanan, Nehru Viji, Afosah, Daniel K, Kumar, Megh, Kummarapurugu, Apparao B, Voynow, Judith A, Desai, Umesh R

    Published in Journal of medicinal chemistry (13-06-2019)
    “…Cystic fibrosis (CF) is a disease of dysregulated salt and fluid homeostasis that results in the massive accumulation of neutrophil elastase, resulting in lung…”
    Get full text
    Journal Article
  17. 17

    A small, synthetic glycosaminoglycan mimetic as an inhibitor of human heparanase by Sistla, Jyothi C., Afosah, Daniel K, Morla, Shravan, Patel, Nirmita J., Patel, Bhaumik B., Desai, Umesh R.

    Published in The FASEB journal (01-04-2019)
    “…Human heparanase (HPSE) is an endo‐b‐D‐glucuronidase that cleaves glycosaminoglycan (GAG) chains of heparan sulfate proteoglycans (HSPGs) present on cell…”
    Get full text
    Journal Article
  18. 18

    Lipophilic Modification of an Anti‐Cancer Stem Cell Agent Improves Pharmacokinetic and Anti‐Cancer Properties by Morla, Shravan, Afosah, Daniel K., O'Hara, Connor, Boothello, Rio, Patel, Bhaumik B., Sakagami, Masahiro, Desai, Umesh R.

    Published in The FASEB journal (01-04-2019)
    “…Current anti‐cancer agents target bulk tumor cells but do not eradicate the rare, quiescent, cancer stem cells (CSCs). CSCs are being increasingly recognized…”
    Get full text
    Journal Article
  19. 19

    Polymeric fluorescent heparin as one-step FRET substrate of human heparanase by Sistla, Jyothi C., Morla, Shravan, Alabbas, Al-Humaidi B., Kalathur, Ravi C., Sharon, Chetna, Patel, Bhaumik B., Desai, Umesh R.

    Published in Carbohydrate polymers (01-02-2019)
    “…•Development of polymeric heparin as a FRET substrate of heparanase.•The FRET substrate enables rapid, one-step screening of heparanase inhibitors.•The FRET…”
    Get full text
    Journal Article
  20. 20